Csk Monoclonal Antibody

catalytic activity:ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.,function:Specifically phosphorylates 'Tyr-504' on LCK, which acts as a negative regulatory site. Can also act on the LYN and FYN kinases.,PTM:Autophosphorylation of Tyr-304 occurs only at abnormally high CSK concentrations in vitro.,similarity:Belongs to the protein kinase superfamily. Tyr protein kinase family.,similarity:Belongs to the protein kinase superfamily. Tyr protein kinase family. CSK subfamily.,similarity:Contains 1 protein kinase domain.,similarity:Contains 1 SH2 domain.,similarity:Contains 1 SH3 domain.,subcellular location:Mainly cytoplasmic, also present in lipid rafts.,subunit:Interacts with PTPN8 (By similarity). Interacts with phosphorylated SIT1, PAG1, LIME1 and TGFB1I1.,tissue specificity:Expressed in lung and macrophages.

Introducing the CSK Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of immunology. This meticulously crafted antibody is derived from a single clone, ensuring exceptional specificity and potency in targeting the C-terminal Src kinase (CSK) protein.

The CSK Monoclonal Antibody boasts an unparalleled level of purity, meticulously purified through advanced chromatographic techniques. This rigorous purification process guarantees a product of utmost quality, free from impurities and contaminants, thus maximizing its efficacy and reliability.

With its remarkable affinity for CSK, this antibody exhibits exceptional binding capabilities, enabling precise and accurate detection of CSK in various biological samples. Its high specificity ensures minimal cross-reactivity, allowing for reliable and reproducible results in a wide range of applications, including Western blotting, immunohistochemistry, and flow cytometry.

Furthermore, the CSK Monoclonal Antibody offers exceptional versatility, making it an invaluable tool for both research and diagnostic purposes. Its robust performance and consistent results make it an ideal choice for scientists and clinicians alike, seeking to unravel the intricate mechanisms of CSK signaling pathways or diagnose CSK-related disorders.

Packaged in a convenient and user-friendly format, the CSK Monoclonal Antibody is ready to use, eliminating the need for time-consuming preparation steps. Its long shelf life ensures prolonged usability, allowing for cost-effective and efficient experimentation.

In summary, the CSK Monoclonal Antibody represents a breakthrough in immunological research, offering unparalleled specificity, potency, and versatility. With its exceptional performance and reliability, this product is poised to redefine the boundaries of scientific discovery and clinical diagnostics.